ClinicalTrials.Veeva

Menu

Non Invasive Evaluation of Fluid Responsiveness in Septic Patient

B

Benha University

Status

Unknown

Conditions

Septic Shock

Study type

Observational

Funder types

Other

Identifiers

NCT05310942
MD17-12-2021

Details and patient eligibility

About

The study aims to evaluate the accuracy of fluid responsiveness assessment with non-invasive cardiometry compared to ultrasound guided inferior vena cava (IVC) collapsibility for management of critically ill septic patients with hemodynamic instability.

Full description

Prospective Randomized observational comparative single blinded study will be conducted at intensive care unit at Benha University Hospitals after obtaining approval of the ethical committee and informed written consent from first degree relatives will be issued. The blindness will be performed to the patients.

The study will be conducted according to CONSORT 2010 statement. Enrolment of eligible patients will occur within 8 h of meeting the criteria for septic shock. All patients will be randomized using the computer-generated software of randomization and sealed closed envelopes to allocate them to one of two groups (30 patients each). Routine measurements and investigations will be taken at admission to intensive care unit; history, vital signs, routine laboratory investigation.

Enrollment

60 patients

Sex

All

Ages

18 to 65 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  1. ASA class I and II
  2. Age 18-65 years old of both genders.
  3. Fulfilment criteria of sepsis as defined according to the standard Surviving Sepsis Campaign criteria using the Sequential (sepsis-related) Organ Failure Assessment (SOFA) score (SOFA score ≥ 2 indicated organ dysfunction).
  4. Patients within 8 h of meeting the criteria for septic shock.

Exclusion criteria

  1. Lack of consent
  2. Age below 18 and above 65 years old.
  3. acute coronary syndrome
  4. major cardiac dysrhythmia,
  5. valvular or congenital heart disease
  6. Massive bilateral pleural effusion
  7. Severe anaemia
  8. End-stage kidney disease (ESKD) patients with Creatinine clearance (CrCl) <50ml/min.
  9. Child B and Child C hepatic patients
  10. impaired systolic function according to the ejection fraction (EF) (EF < 40% indicated impaired systolic function)
  11. Severe ARDS (acute respiratory distress syndrome).
  12. Tense ascites
  13. Mechanical ventilation.

Trial design

60 participants in 2 patient groups

A
Description:
The fluid management of patients in this group will be assessed by IVC collapsibility index (IVC CI) calculated by ultrasound through maximum IVC diameter - minimum IVC diameter divided by maximum diameter then multiplied by 100. If it is less than 50% means that the patient is volume non- depleted while if it is more than 50% means the reverse.
B
Description:
All patients in this group with sepsis will be evaluated by the electrical cardiometry monitor.

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems